182 related articles for article (PubMed ID: 10404957)
21. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury.
Miyazaki M; Wada T; Shiota N; Takai S
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S21-5; discussion S33-4. PubMed ID: 10076917
[TBL] [Abstract][Full Text] [Related]
22. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity.
Kokkonen JO; Saarinen J; Kovanen PT
Circulation; 1997 Mar; 95(6):1455-63. PubMed ID: 9118513
[TBL] [Abstract][Full Text] [Related]
23. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
Liao Y; Husain A
Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
[TBL] [Abstract][Full Text] [Related]
24. [Plaque progression and destabilization in human coronary arteries].
Komatsu R; Ueda M
Nihon Rinsho; 1998 Oct; 56(10):2477-82. PubMed ID: 9796305
[TBL] [Abstract][Full Text] [Related]
25. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
Urata H; Ganten D
Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
[TBL] [Abstract][Full Text] [Related]
26. Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation.
Nishimoto M; Takai S; Kim S; Jin D; Yuda A; Sakaguchi M; Yamada M; Sawada Y; Kondo K; Asada K; Iwao H; Sasaki S; Miyazaki M
Circulation; 2001 Sep; 104(11):1274-9. PubMed ID: 11551879
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
28. Expression of angiotensin converting enzyme and chymase in human atria.
Ohmichi N; Iwai N; Kinoshita M
J Hypertens; 1997 Sep; 15(9):935-43. PubMed ID: 9321740
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations.
Balcells E; Meng QC; Johnson WH; Oparil S; Dell'Italia LJ
Am J Physiol; 1997 Oct; 273(4):H1769-74. PubMed ID: 9362242
[TBL] [Abstract][Full Text] [Related]
30. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
[TBL] [Abstract][Full Text] [Related]
31. Induction of local angiotensin II-producing systems in stenotic aortic valves.
Helske S; Lindstedt KA; Laine M; Mäyränpää M; Werkkala K; Lommi J; Turto H; Kupari M; Kovanen PT
J Am Coll Cardiol; 2004 Nov; 44(9):1859-66. PubMed ID: 15519020
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the angiotensin II-forming pathway in human atria.
Ohmichi N; Iwai N; Shimoike H; Izumi M; Watarida S; Mori A; Nakamura Y; Kinoshita M
Heart Vessels; 1997; Suppl 12():116-8. PubMed ID: 9476560
[TBL] [Abstract][Full Text] [Related]
33. Activation of two angiotensin-generating systems in the balloon-injured artery.
Shiota N; Okunishi H; Fukamizu A; Sakonjo H; Kikumori M; Nishimura T; Nakagawa T; Murakami K; Miyazaki M
FEBS Lett; 1993 Jun; 323(3):239-42. PubMed ID: 7684709
[TBL] [Abstract][Full Text] [Related]
34. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.
Shiota N; Fukamizu A; Takai S; Okunishi H; Murakami K; Miyazaki M
J Hypertens; 1997 Apr; 15(4):431-40. PubMed ID: 9211178
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II-generating system in dog and monkey ocular tissues.
Shiota N; Saegusa Y; Nishimura K; Miyazaki M
Clin Exp Pharmacol Physiol; 1997; 24(3-4):243-8. PubMed ID: 9131292
[TBL] [Abstract][Full Text] [Related]
36. Chymase-dependent angiotensin II forming systems in humans.
Urata H; Nishimura H; Ganten D
Am J Hypertens; 1996 Mar; 9(3):277-84. PubMed ID: 8695029
[TBL] [Abstract][Full Text] [Related]
37. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
Urata H; Boehm KD; Philip A; Kinoshita A; Gabrovsek J; Bumpus FM; Husain A
J Clin Invest; 1993 Apr; 91(4):1269-81. PubMed ID: 7682566
[TBL] [Abstract][Full Text] [Related]
38. Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation.
Nakagawa-Toyama Y; Yamashita S; Miyagawa J; Nishida M; Nozaki S; Nagaretani H; Sakai N; Hiraoka H; Yamamori K; Yamane T; Hirano K; Matsuzawa Y
Atherosclerosis; 2001 Jun; 156(2):297-305. PubMed ID: 11395025
[TBL] [Abstract][Full Text] [Related]
39. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
40. Conversion of angiotensin I to angiotensin II by chymase activity in human pulmonary membranes.
Lindberg BF; Gyllstedt E; Andersson KE
Peptides; 1997; 18(6):847-53. PubMed ID: 9285934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
